Concord Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Concord Medical Services
CCM Stock  USD 3.97  0.07  1.79%   
Concord Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Concord Medical's valuation are provided below:
Gross Profit
-41.8 M
Profit Margin
(0.45)
Market Capitalization
17.2 M
Enterprise Value Revenue
10.2878
Revenue
365.8 M
There are over one hundred nineteen available fundamental signals for Concord Medical Services, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to validate Concord Medical's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 5th of February 2026, Enterprise Value is likely to grow to about 3.5 B, while Market Cap is likely to drop about 6.2 M.

Concord Medical Total Revenue

417.67 Million

Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord Medical's main balance sheet or income statement drivers, such as Interest Expense of 233.3 M, Selling General Administrative of 488.3 M or Total Revenue of 417.7 M, as well as many indicators such as Price To Sales Ratio of 0.0163, Dividend Yield of 5.83 or Days Sales Outstanding of 53.14. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.
  
Build AI portfolio with Concord Stock
Check out the analysis of Concord Medical Correlation against competitors.

Concord Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.2 B7.7 B4.4 B
Slightly volatile
Other Current Liabilities926.6 M882.4 M404.5 M
Slightly volatile
Total Current Liabilities2.6 B2.4 B1.1 B
Slightly volatile
Other Liabilities324.7 M309.2 M164.3 M
Slightly volatile
Cash231.9 M194.6 M218.6 M
Very volatile
Other Assets26.2 M27.6 M286.8 M
Very volatile
Long Term Debt3.3 B3.1 B1.2 B
Slightly volatile
Common Stock Shares Outstanding124.5 K131 K6.4 M
Slightly volatile
Other Current Assets356.6 M630.8 M382 M
Pretty Stable
Total Liabilities6.2 B5.9 B2.8 B
Slightly volatile
Intangible Assets453.1 M782.4 M480.4 M
Slightly volatile
Common Stock106.5 K120.8 K100.1 K
Slightly volatile
Property Plant Equipment4.7 B4.4 B2 B
Slightly volatile
Short and Long Term Debt Total4.7 B4.5 B2 B
Slightly volatile
Property Plant And Equipment Net4.8 B4.6 B2.3 B
Slightly volatile
Current Deferred Revenue33.5 M53.1 M34.2 M
Slightly volatile
Accounts Payable240.8 M229.3 M79.4 M
Slightly volatile
Non Current Assets Total3.5 B6.6 B3.6 B
Slightly volatile
Non Currrent Assets Other5 M5.3 M187.9 M
Slightly volatile
Cash And Short Term Investments256.8 M315.8 M262 M
Pretty Stable
Net Receivables43.7 M46.1 M236.2 M
Slightly volatile
Common Stock Total Equity111.2 K120.8 K103.3 K
Slightly volatile
Liabilities And Stockholders Equity4.5 B7.7 B4.5 B
Slightly volatile
Non Current Liabilities Total3.6 B3.4 B1.7 B
Slightly volatile
Other Stockholder Equity1.6 B2 B2 B
Pretty Stable
Property Plant And Equipment Gross5.3 B5.1 B2.4 B
Slightly volatile
Total Current Assets740.7 M885.6 M895.8 M
Pretty Stable
Short Term Debt1.3 B1.2 B611.2 M
Slightly volatile
Inventory28.2 M30.1 M27.9 M
Very volatile
Deferred Long Term Liabilities1.5 M2 M1.4 M
Slightly volatile
Long Term Investments336.1 M543 M305.8 M
Slightly volatile
Short and Long Term Debt1.2 B1.2 B712 M
Very volatile
Long Term Debt Total2.6 B2.5 B1.1 B
Slightly volatile
Capital Surpluse1.8 B2.2 B1.3 B
Slightly volatile
Cash And Equivalents230.8 M181 M193.1 M
Very volatile
Net Invested Capital1.1 B1.3 B1.7 B
Slightly volatile
Capital Stock84 K94.5 K103.1 K
Slightly volatile

Concord Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative488.3 M465 M244 M
Slightly volatile
Total Revenue417.7 M441.5 M402.4 M
Very volatile
Cost Of Revenue292.4 M532.6 M314.9 M
Slightly volatile
Depreciation And Amortization124 M150.4 M117.9 M
Very volatile
Selling And Marketing Expenses54.7 M55.9 M54.8 M
Very volatile
Other Operating Expenses589.9 M1.1 B613.3 M
Slightly volatile
Total Operating Expenses280.3 M520.9 M294.7 M
Slightly volatile
Minority Interest663 M395.4 M594.1 M
Slightly volatile
Interest Income17.4 M12.6 M16.9 M
Very volatile
Reconciled Depreciation107.5 M150.4 M100.2 M
Slightly volatile

Concord Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures309.8 M472.5 M329.6 M
Slightly volatile
End Period Cash Flow307.6 M213.3 M324.5 M
Very volatile
Begin Period Cash Flow77.3 M81.4 M320.7 M
Pretty Stable
Depreciation126.7 M150.4 M120.4 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.01630.01710.5785
Slightly volatile
Dividend Yield5.835.555.006
Slightly volatile
Days Sales Outstanding53.1455.94213
Slightly volatile
Book Value Per Share11.7 K10 K15.8 K
Slightly volatile
Capex To Depreciation2.682.833.5361
Slightly volatile
EV To Sales9.168.724.9493
Slightly volatile
Inventory Turnover15.1315.9328.9975
Pretty Stable
Days Of Inventory On Hand28.7930.3153.9034
Slightly volatile
Payables Turnover2.542.6762.2762
Slightly volatile
Sales General And Administrative To Revenue1.00.950.6797
Slightly volatile
Capex To Revenue0.790.961.0563
Slightly volatile
Cash Per Share1.5 K2.2 K2 K
Pretty Stable
Days Payables Outstanding14914176.7649
Pretty Stable
Intangibles To Total Assets0.130.170.1617
Pretty Stable
Current Ratio0.510.531.1549
Slightly volatile
Tangible Book Value Per Share2.1 K2.3 K8.3 K
Pretty Stable
Receivables Turnover7.096.752.8682
Slightly volatile
Capex Per Share2.6 K2.5 K3.6 K
Slightly volatile
Revenue Per Share2.2 K2.4 K3 K
Slightly volatile
Interest Debt Per Share26.8 K25.5 K18.3 K
Slightly volatile
Debt To Assets0.550.530.3719
Slightly volatile
Graham Number374356329
Slightly volatile
Operating Cycle81.9486.25241
Slightly volatile
Days Of Payables Outstanding14914176.7649
Pretty Stable
Total Debt To Capitalization2.252.141.1739
Slightly volatile
Quick Ratio0.490.511.1185
Slightly volatile
Net Income Per E B T0.50.531.5892
Pretty Stable
Cash Ratio0.110.120.3909
Slightly volatile
Days Of Inventory Outstanding28.7930.3153.9034
Slightly volatile
Days Of Sales Outstanding53.1455.94213
Slightly volatile
Fixed Asset Turnover0.10.110.3001
Slightly volatile
Debt Ratio0.550.530.3719
Slightly volatile
Price Sales Ratio0.01630.01710.5785
Slightly volatile
Asset Turnover0.120.06560.1056
Slightly volatile

Concord Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap6.2 M6.6 M155.1 M
Slightly volatile
Enterprise Value3.5 B3.3 B1.8 B
Slightly volatile

Concord Fundamental Market Drivers

Concord Upcoming Events

17th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Concord Medical Financial Statements

Concord Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Concord Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue53.1 M33.5 M
Total Revenue441.5 M417.7 M
Cost Of Revenue532.6 M292.4 M
Stock Based Compensation To Revenue(0.01)(0.01)
Sales General And Administrative To Revenue 0.95  1.00 
Capex To Revenue 0.96  0.79 
Revenue Per Share2.4 K2.2 K
Ebit Per Revenue(1.59)(1.51)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
How To Invest In Concord
Details
Is Concord Stock a good investment?
Details
What is Concord Medical's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Concord Medical Correlation against competitors.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(5.50)
Revenue Per Share
83.728
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.04)
Return On Equity
(0.29)
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY